Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer.
作者信息
Lambertini Matteo, Viglietti Giulia
机构信息
Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
出版信息
Oncotarget. 2019 Jan 25;10(8):803-804. doi: 10.18632/oncotarget.26611.
Abstract
摘要
相似文献
1
Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer.
Oncotarget. 2019 Jan 25;10(8):803-804. doi: 10.18632/oncotarget.26611.
2
Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network.
Breast. 2020 Dec;54:311-318. doi: 10.1016/j.breast.2020.11.013. Epub 2020 Nov 26.
3
Hypothesized role of pregnancy hormones on HER2+ breast tumor development.
Breast Cancer Res Treat. 2013 Jan;137(1):237-46. doi: 10.1007/s10549-012-2313-0. Epub 2012 Nov 8.
4
Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.
Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1297-304. doi: 10.1158/1055-9965.EPI-15-1104. Epub 2016 Jun 15.
5
Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Int J Cancer. 2019 Mar 15;144(6):1251-1261. doi: 10.1002/ijc.31950. Epub 2018 Dec 3.
6
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x.
7
The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Breast J. 2018 Mar;24(2):148-153. doi: 10.1111/tbj.12853. Epub 2017 Jul 14.
8
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
Cancer. 2019 Jan 15;125(2):307-316. doi: 10.1002/cncr.31784. Epub 2018 Oct 18.
9
Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.
Breast J. 2019 Nov;25(6):1104-1110. doi: 10.1111/tbj.13431. Epub 2019 Jul 18.
10
HR+/Her2- breast cancer in pre-menopausal women: The impact of younger age on clinical characteristics at diagnosis, disease management and survival.
Cancer Epidemiol. 2016 Dec;45:162-168. doi: 10.1016/j.canep.2016.10.019. Epub 2016 Nov 12.
引用本文的文献
1
Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate.
Curr Oncol. 2023 May 8;30(5):4833-4843. doi: 10.3390/curroncol30050364.
2
Cancer Treatment and Immunotherapy during Pregnancy.
Pharmaceutics. 2022 Sep 29;14(10):2080. doi: 10.3390/pharmaceutics14102080.
3
The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer.
Acta Naturae. 2022 Apr-Jun;14(2):4-15. doi: 10.32607/actanaturae.11611.
4
Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.
ESMO Open. 2020 Oct;5(Suppl 4):e000771. doi: 10.1136/esmoopen-2020-000771.
本文引用的文献
1
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
Cancer. 2019 Jan 15;125(2):307-316. doi: 10.1002/cncr.31784. Epub 2018 Oct 18.
2
Suboptimal Use of Effective Contraceptive Methods in Young Mexican Women With Breast Cancer.
J Glob Oncol. 2018 Oct;4:1-7. doi: 10.1200/JGO.18.00064.
3
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients.
Breast. 2018 Dec;42:41-49. doi: 10.1016/j.breast.2018.08.099. Epub 2018 Aug 22.
4
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.
5
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
J Natl Cancer Inst. 2018 Apr 1;110(4):426-429. doi: 10.1093/jnci/djx206.
6
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
Breast. 2017 Oct;35:203-217. doi: 10.1016/j.breast.2017.07.017. Epub 2017 Aug 17.
7
The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis.
Breast Cancer Res Treat. 2016 Nov;160(2):347-360. doi: 10.1007/s10549-016-3989-3. Epub 2016 Sep 28.
8
Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients.
JAMA Oncol. 2015 Nov;1(8):1145-53. doi: 10.1001/jamaoncol.2015.2413.
9
Targeted agents for cancer treatment during pregnancy.
Cancer Treat Rev. 2015 Apr;41(4):301-9. doi: 10.1016/j.ctrv.2015.03.001. Epub 2015 Mar 13.
10
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2013 Oct;24 Suppl 6:vi160-70. doi: 10.1093/annonc/mdt199. Epub 2013 Jun 27.
Zotero 插件